US2022055977A1PendingUtilityA1

Therapeutic compounds and methods of use thereof

75
Assignee: GENENTECH INCPriority: Aug 27, 2015Filed: Aug 6, 2021Published: Feb 24, 2022
Est. expiryAug 27, 2035(~9.1 yrs left)· nominal 20-yr term from priority
C07C 229/48C07C 313/04C07D 211/22C07C 2601/08C07C 62/38C07C 2603/74A61P 29/00C07C 317/44A61P 17/04C07C 323/61C07C 2601/14C07C 69/757C07C 62/34C07C 2601/02C07C 2601/04A61P 25/00
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a method of treating a disease or condition in a mammal by administering a compound having the general formula I:or a pharmaceutically acceptable salt thereof, wherein the variables RAA, n, ring A, X1, L, m, X2, R2, R3, R4, R5, X, and R6 have the meaning as described herein.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of treating a disease or condition in a mammal selected from the group consisting of pain, depression, cardiovascular diseases, respiratory diseases, and psychiatric diseases, and combinations thereof, wherein the method comprises administering to the mammal in need thereof a therapeutically effective amount of a compound of Formula I: 
       
         
           
           
               
               
           
         
         or a salt thereof; wherein 
         each R AA  is independently selected from the group consisting of F, Cl, Br, I, —CN, —OR A1 , —(X RA )-(6-12 membered aryl), —(X RA )-(5-12 membered heteroaryl), and —R A2 , wherein said 6-12 membered aryl and 5-12 membered heteroaryl of R AA  is optionally substituted with from 1 to 5 substitutents independently selected from the group consisting of F, Cl, Br, I, C 1-4  alkyl, C 1-4  haloalkyl, and C 1-4 (halo)alkoxy; R A1  is selected from the group consisting of hydrogen, C 1-8  alkyl, C 2-8  alkenyl, C 1-8  haloalkyl, C 3-8  cycloalkyl, phenyl and benzyl; R A2  is selected from the group consisting of C 1-8  alkyl that is optionally substituted with one or more substituents selected from oxo (═O), fluoro, amino, C 1-4  alkylamino and di(C 1-4 alkyl)amino; X KA  is selected from the group consisting of absent, —C(═O)—, and C 1-4  alkylene; wherein any C 1-4  alkylene of X RA  is optionally substituted with 1 to 3 substituents selected from the group consisting of C 1-4  alkyl, C 1-4  haloalkyl, and phenyl that is optionally substituted with 1 to 5 substitutents selected from, F, Cl, Br, I, —NH 2 , —OH, —CN, —NO 2 , C 1-4  alkyl, C 1-4  haloalkyl, C 1-4 alkoxy, C 1-4 (halo)alkoxy, C 1-4  alkylamino and C 1-4  dialkylamino; 
         n is 0, 1, 2, 3, 4, 5, 6, 7, or 8; 
         ring “A” is a 3-15 membered carbocyclyl, a 6-12 membered aryl, a 5-12 membered heteroaryl, or a 3-15 membered heterocyclyl; 
         X 1  and X 2  are each independently selected from the group consisting of absent, —S—, —O— and —N(R X )— wherein R x  is H, C 1-8  alkyl, or C 1-8  haloalkyl, and wherein if the subscript m is 0 then one of X 1  or X 2  is absent; 
         L is C 1-6  alkylene, wherein L is optionally substituted with from 1 to 3 substituents independently selected from the group consisting of C 1-4  alkyl, C 1-4  alkoxy, halo, oxo (═O), and C 1-4  haloalkyl; wherein any two substituents attached to the same atom on L are optionally combined to form a 3- to 5-membered carbocyclic ring; 
         m is 0 or 1; 
         R 2  is selected from the group consisting of F, Cl, Br, I, and C 3-8  cycloalkyl; 
         R 4  is selected from the group consisting of F, Cl, Br, I, and C 1-8  haloalkyl; 
         and R 5  are each independently selected from the group consisting of H, F, Cl, Br, I, —CN, C 1-8  alkyl, C 3-8  cycloalkyl, C 1-8  haloalkyl and C 1-8  alkoxy; 
         X is selected from the group consisting of O, S, S═O, SO 2 , N(R N ), C═O, CH 2 , and C═S, wherein R N  is selected from the group consisting of H, C 1-6  alkyl and acyl; 
         ring “B” is selected from the group consisting of cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl, wherein ring B is optionally substituted with one or more groups independently selected from C 1-4  alkyl; and 
         R 6  is hydrogen or C 1-6  alkyl. 
       
     
     
         2 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Ia): 
       
         
           
           
               
               
           
         
       
     
     
         3 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Id): 
       
         
           
           
               
               
           
         
       
     
     
         4 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Ie): 
       
         
           
           
               
               
           
         
       
     
     
         5 . The method of  claim 1 , wherein ring “B” is selected from the group consisting of cyclobutyl, cyclopentyl, and cyclohexyl. 
     
     
         6 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Ik): 
       
         
           
           
               
               
           
         
       
     
     
         7 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Im): 
       
         
           
           
               
               
           
         
       
     
     
         8 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (In): 
       
         
           
           
               
               
           
         
       
     
     
         9 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Io): 
       
         
           
           
               
               
           
         
       
     
     
         10 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Ip): 
       
         
           
           
               
               
           
         
       
     
     
         11 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Iq): 
       
         
           
           
               
               
           
         
       
     
     
         12 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Ir): 
       
         
           
           
               
               
           
         
       
     
     
         13 . The method of  claim 1 , wherein the compound of formula (I) is a compound of formula (Is): 
       
         
           
           
               
               
           
         
       
     
     
         14 . The method of  claim 1 , wherein wherein n is 2, 3, 4, or 5. 
     
     
         15 . The method of  claim 1 , wherein ring “A” is a 6-15 membered carbocycle, a 6-10 membered aryl, or a 4-6 membered heterocycle. 
     
     
         16 . The method of  claim 1 , wherein ring “A” is selected from: 
       
         
           
           
               
               
           
         
       
     
     
         17 . The method of  claim 1 , wherein the group 
       
         
           
           
               
               
           
         
       
       is selected from the group consisting of: 
       
         
           
           
               
               
           
         
       
     
     
         18 . The method of  claim 1 , wherein X 1  is absent; X 2  is —O—; m is 1; and -(L)- is an optionally substituted C 1-4  alkylene. 
     
     
         19 . The method of  claim 1 , wherein wherein:
 ring “A” is a 6-15 membered carbocycle, a 6-10 membered aryl, or a 4-6 membered heterocycle;   X 1  is absent;   X 2  is —O—;   m is 1; and   -(L)- is an optionally substituted C 1-4  alkylene.   
     
     
         20 . The method of  claim 1 , wherein the compound of formula (I) is selected from the group consisting of:

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.